Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
Health & MedicineOne-Off3yManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 59.7%
Forecasters
16
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 36 minutes ago
Oct 4, 24, 9:38 PM UTCNov 1, 29, 6:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Manifold MarketsNobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
Manifold MarketsWill a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
Manifold MarketsWill GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
Manifold MarketsPandemic in 2026?
KalshiPlague pandemic in 2026?
PolymarketRules
Richard Hanania posed the question if we'll see a partisan gap around Ozempic: https://x.com/RichardHanania/status/1842283808890175877
- This will resolve YES if during any point in the next 5 years we'll get any data that shows a significant difference in attitude towards Ozempic based on party affiliation.
- The measure of "significant" and how we capture the attitude is somewhat subjective, so I won't be betting in this market.
- If a survey asked a question like "would you ever consider taking Ozempic?", "Is Ozempic an acceptable form of weightloss?" or even "Do you think Ozempic is safe?" (COVID vaccine repeat) and the difference by party is >= 30%, I'd see this as resolved.
- The core is that the topic of Ozempic has to become politicized.
- It does not matter which side feels better/worse about Ozempic.